| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Medicine, Gastroenterology Division [A. S. F., Y. X., J. L., J. Y., T-T. Z., J. M. A., D. K., K. T. W., S. P. J, S. J. M.], Greenebaum Cancer Center [S. J. M.], Program in Genetics [A. R., O. C. S.], Department of Pathology [D. K.], and Molecular and Cell Biology Graduate Program [J. L., S. J. M.], University of Maryland School of Medicine and Baltimore Veterans Affairs Hospital, Baltimore, Maryland 21201; The Johns Hopkins Oncology Center, Baltimore, Maryland 21231 [M. E., J. G. H.]; and Department of Pathology, Mt. Sinai School of Medicine of New York University, New York, New York 10021 [N. H., A. L.]
Twelve to 15% of sporadic colorectal cancers display defective DNA mismatch repair (MMR), manifested as microsatellite instability (MSI). In this group of cancers, promoter hypermethylation of the MMR gene hMLH1 is strongly associated with, and believed to be the cause of, MSI. A subset of colorectal neoplastic lesions arising in inflammatory bowel disease (IBD) is also characterized by MSI. We wished to determine whether hMLH1 hypermethylation was associated with diminished hMLH1 protein expression and MSI in IBD neoplasms. We studied 148 patients with IBD neoplasms, defined as carcinoma or dysplasia occurring in patients with ulcerative colitis or Crohn’s disease. MSI was evaluated using multiplex fluorescent PCR to amplify loci D2S123, BAT-25, BAT-26, D5S346, and D17S250 in all cases. Lesions were characterized as high-frequency MSI (MSI-H) if they manifested instability at two or more loci, low-frequency MSI (MSI-L) if unstable at only one locus, or MS-stable (MSS) if showing no instability at any loci. Methylation-specific PCR was performed to determine the methylation status of the hMLH1 promoter region. hMLH1 protein expression was also evaluated by immunohistochemistry. Thirteen (9%) of 148 neoplasms arising in IBD were MSI-H, comprising 11 carcinomas and 2 dysplastic lesions. Sixteen additional lesions (11%) were MSI-L, comprising 11 carcinomas and 5 dysplastic lesions. The remaining 118 neoplasms (80%) were MSS. Six (46%) of 13 MSI-H, 1 (6%) of 16 MSI-L, and 4 (15%) of 27 MSS lesions showed hMLH1 hypermethylation (P = 0.013). Diminished hMLH1 protein expression in neoplastic cell nuclei relative to surrounding normal cell nuclei was demonstrated immunohistochemically in four of four (100%) hypermethylated lesions tested. In IBD neoplasia, hMLH1 promoter hypermethylation occurs frequently in the setting of MSI, particularly MSI-H. Furthermore, hMLH1 hypermethylation and MSI are strongly associated with diminished hMLH1 protein expression in IBD neoplasms. These findings suggest that hMLH1 hypermethylation causes defective DNA MMR in at least a subset of IBD neoplasms.
This article has been cited by other articles:
|
|
 |
|
  F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis, July 1, 2009; 30(7): 1073 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Svrcek, J. El-Bchiri, A. Chalastanis, E. Capel, S. Dumont, O. Buhard, C. Oliveira, R. Seruca, C. Bossard, J.-F. Mosnier, et al. Specific Clinical and Biological Features Characterize Inflammatory Bowel Disease Associated Colorectal Cancers Showing Microsatellite Instability J. Clin. Oncol., September 20, 2007; 25(27): 4231 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Chen, S.-Y. Yang, C.-J. Liu, C.-L. Lin, Y.-F. Liaw, S.-M. Lin, S.-D. Lee, P.-J. Chen, C.-J. Chen, and M.-W. Yu Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma Int. J. Epidemiol., December 1, 2005; 34(6): 1310 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C R Boland, M G Luciani, C Gasche, and A Goel INFECTION, INFLAMMATION, AND GASTROINTESTINAL CANCER Gut, September 1, 2005; 54(9): 1321 - 1331. [Full Text] [PDF]
|
|
|
|
|
|
Y.N. Ye, W.K.K. Wu, V.Y. Shin, I.C. Bruce, B.C.Y. Wong, and C.H. Cho Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke Carcinogenesis, April 1, 2005; 26(4): 827 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Stringer, J. S. Larson, J. M. Fischer, M. Medvedovic, M. N. Hersh, G. P. Boivin, and S. L. Stringer Modeling variation in tumors in vivo PNAS, February 15, 2005; 102(7): 2408 - 2413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Belshaw, G. O. Elliott, E. A. Williams, D. M. Bradburn, S. J. Mills, J. C. Mathers, and I. T. Johnson Use of DNA from Human Stools to Detect Aberrant CpG Island Methylation of Genes Implicated in Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1495 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Itzkowitz and X. Yio Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G7 - G17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Matsumoto, T. Yoshida, and I. Okayasu High Epithelial and Stromal Genetic Instability of Chromosome 17 in Ulcerative Colitis-associated Carcinogenesis Cancer Res., October 1, 2003; 63(19): 6158 - 6161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ezaki, M. Watanabe, N. Inoue, T. Kanai, H. Ogata, Y. Iwao, H. Ishii, and T. Hibi A Specific Genetic Alteration on Chromosome 6 in Ulcerative Colitis-associated Colorectal Cancers Cancer Res., July 1, 2003; 63(13): 3747 - 3749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Seril, J. Liao, G.-Y. Yang, and C. S. Yang Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis, March 1, 2003; 24(3): 353 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sato, D. Shibata, N. Harpaz, Y. Xu, J. Yin, Y. Mori, S. Wang, A. Olaru, E. Deacu, F. M. Selaru, et al. Aberrant Methylation of the HPP1 Gene in Ulcerative Colitis-associated Colorectal Carcinoma Cancer Res., December 1, 2002; 62(23): 6820 - 6822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Chang, G. Marra, D. P. Chauhan, H. T. Ha, D. K. Chang, L. Ricciardiello, A. Randolph, J. M. Carethers, and C. R. Boland Oxidative stress inactivates the human DNA mismatch repair system Am J Physiol Cell Physiol, July 1, 2002; 283(1): C148 - C154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. J. Kohonen-Corish, J. J. Daniel, H. te Riele, G. D. Buffinton, and J. E. Dahlstrom Susceptibility of Msh2-deficient Mice to Inflammation-associated Colorectal Tumors Cancer Res., April 1, 2002; 62(7): 2092 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gasche, C. L. Chang, J. Rhees, A. Goel, and C. R. Boland Oxidative Stress Increases Frameshift Mutations in Human Colorectal Cancer Cells Cancer Res., October 1, 2001; 61(20): 7444 - 7448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, P. G. Corn, S. B. Baylin, and J. G. Herman A Gene Hypermethylation Profile of Human Cancer Cancer Res., April 1, 2001; 61(8): 3225 - 3229. [Abstract] [Full Text]
|
|
|
|
|
|
M. Akhtar, Y. Cheng, R. M. Magno, H. Ashktorab, D. T. Smoot, S. J. Meltzer, and K. T. Wilson Promoter Methylation Regulates Helicobacter pylori-stimulated Cyclooxygenase-2 Expression in Gastric Epithelial Cells Cancer Res., March 1, 2001; 61(6): 2399 - 2403. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
